By: Robby Berman
Semaglutide drugs aid weight loss and heart health but does that come at the expense of gut health? Image credit: Douglas Cliff/Getty Images.
Robby Berman is a writer at Medical News Today. With a focus on medicine and healthcare, he explores topics such as nutrition, fitness, and social issues, while also delving into alternative medicine and wellness. Robby's work has been featured in Haaretz Daily Newspaper Ltd, The Forward, Freethink, AOL, Inc., and NewsBreak.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Robby Berman primarily focuses on health and scientific topics, often citing data to support his articles. His coverage includes a wide range of health-related themes such as weight loss, chronic fatigue syndrome, cognitive health, dementia, nutrition, sleep, diabetes and heart health.
To effectively reach out to Robby with pitches or expert commentary, it's important to provide evidence-based insights supported by credible data. This could include the latest research findings related to the topics he covers or access to experts who can offer authoritative perspectives based on scientific evidence.
Given his focus on diverse health topics and reliance on data-driven content creation process for most of his articles (97%), providing well-researched information backed by reliable sources would be crucial when reaching out to him.
This information evolves through artificial intelligence and human feedback. Improve this profile .